Phase Ib Study Of Drozitumab Combined With Cetuximab (Cet) Plus Irinotecan (Iri) Or With Folfiri +/- Bevacizumab (Bv) In Previously Treated Patients (Pts) With Metastatic Colorectal Cancer (Mcrc)
JOURNAL OF CLINICAL ONCOLOGY（2011）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要